Prostate Cancer Medicine Market Report

Global and China Prostate Cancer Medicine Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 22, 2022
  • PAGES：224
  • REPORT CODE：GMM1484207
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prostate Cancer Medicine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Abbott Laboratories

    • Active Biotech

    • Astellas Pharma Inc

    • Roche Holding AG

    • Teva Pharmaceuticals Industries Ltd

    • Bristol Myers-Squibb

    • AstraZeneca plc

    • Pfizer Inc

    • Johnson & Johnson

    • Bayer AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • LHRH Antagonists

    • LHRH Analogs

    • Antiandrogens

    • Pipeline Drugs for Hormonal Therapy

    Application:

    • Hospitals

    • Clinics

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prostate Cancer Medicine Industry Overview

      • 1.1.1 Prostate Cancer Medicine Market Scope and Market Segments

      • 1.1.2 Prostate Cancer Medicine Industry Characteristics

      • 1.1.3 Global and China Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prostate Cancer Medicine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prostate Cancer Medicine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 LHRH Antagonists

      • 1.2.2 LHRH Analogs

      • 1.2.3 Antiandrogens

      • 1.2.4 Pipeline Drugs for Hormonal Therapy

    • 1.3 Global Prostate Cancer Medicine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prostate Cancer Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prostate Cancer Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prostate Cancer Medicine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prostate Cancer Medicine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prostate Cancer Medicine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prostate Cancer Medicine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prostate Cancer Medicine Industry PEST Analysis

    • 2.3 Prostate Cancer Medicine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prostate Cancer Medicine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prostate Cancer Medicine Industry

    Chapter 3 Global and China Prostate Cancer Medicine Market, by Manufacturer

    • 3.1 Global and China Prostate Cancer Medicine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prostate Cancer Medicine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prostate Cancer Medicine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prostate Cancer Medicine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prostate Cancer Medicine Market Top 3 Players

    Chapter 4 Global and China Prostate Cancer Medicine Market, by Type (2017-2028)

    • 4.1 Prostate Cancer Medicine Market Trend, by Type

    • 4.2 Global Prostate Cancer Medicine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prostate Cancer Medicine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prostate Cancer Medicine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prostate Cancer Medicine Price Trend, by Type (2017-2028)

    • 4.3 China Prostate Cancer Medicine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prostate Cancer Medicine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prostate Cancer Medicine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prostate Cancer Medicine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prostate Cancer Medicine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prostate Cancer Medicine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prostate Cancer Medicine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prostate Cancer Medicine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prostate Cancer Medicine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prostate Cancer Medicine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prostate Cancer Medicine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prostate Cancer Medicine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prostate Cancer Medicine Market Analysis

    • 7.1 North America Prostate Cancer Medicine Market, by Type

    • 7.2 North America Prostate Cancer Medicine Market, by Application

    • 7.3 North America Prostate Cancer Medicine Market Analysis and Forecast, by Country

      • 7.3.1 United States Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prostate Cancer Medicine Market Analysis

    • 8.1 Europe Prostate Cancer Medicine Market, by Type

    • 8.2 Europe Prostate Cancer Medicine Market, by Application

    • 8.3 Europe Prostate Cancer Medicine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prostate Cancer Medicine Market Analysis

    • 9.1 APAC Prostate Cancer Medicine Market, by Type

    • 9.2 APAC Prostate Cancer Medicine Market, by Application

    • 9.3 APAC Prostate Cancer Medicine Market Analysis and Forecast, by Country

      • 9.3.1 China Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prostate Cancer Medicine Market Analysis

    • 10.1 Latin America, Middle East and Africa Prostate Cancer Medicine Market, by Type

    • 10.2 Latin America, Middle East and Africa Prostate Cancer Medicine Market, by Application

    • 10.3 Latin America, Middle East and Africa Prostate Cancer Medicine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prostate Cancer Medicine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prostate Cancer Medicine Company Profiles

      • 11.1 Abbott Laboratories

        • 11.1.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Abbott Laboratories Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.1.3 Abbott Laboratories Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Active Biotech

        • 11.2.1 Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Active Biotech Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.2.3 Active Biotech Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Astellas Pharma Inc

        • 11.3.1 Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Astellas Pharma Inc Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.3.3 Astellas Pharma Inc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Roche Holding AG

        • 11.4.1 Roche Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Roche Holding AG Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.4.3 Roche Holding AG Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Teva Pharmaceuticals Industries Ltd

        • 11.5.1 Teva Pharmaceuticals Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.5.3 Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Bristol Myers-Squibb

        • 11.6.1 Bristol Myers-Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Bristol Myers-Squibb Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.6.3 Bristol Myers-Squibb Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 AstraZeneca plc

        • 11.7.1 AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 AstraZeneca plc Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.7.3 AstraZeneca plc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pfizer Inc

        • 11.8.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pfizer Inc Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.8.3 Pfizer Inc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Johnson & Johnson

        • 11.9.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Johnson & Johnson Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.9.3 Johnson & Johnson Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Bayer AG

        • 11.10.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Bayer AG Prostate Cancer Medicine Product Profiles, Application and Specification

        • 11.10.3 Bayer AG Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prostate Cancer Medicine Industry Investment Prospect and Risk Assessment

    • 12.1 Prostate Cancer Medicine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prostate Cancer Medicine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Medicine Production Value and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Medicine Production Value and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of LHRH Antagonists (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of LHRH Analogs (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of Antiandrogens (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of Pipeline Drugs for Hormonal Therapy (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Prostate Cancer Medicine Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Medicine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Medicine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prostate Cancer Medicine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Medicine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Medicine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prostate Cancer Medicine Market Share, by Manufacturer in 2021

    • Figure Global and China Prostate Cancer Medicine Market Share, by Manufacturer in 2022

    • Table Global Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Value, by Type (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Value Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Medicine Price Trend, by Type (2017-2028)

    • Table China Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table China Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table China Prostate Cancer Medicine Sales Value, by Type (2017-2028)

    • Table China Prostate Cancer Medicine Sales Value Share, by Type (2017-2028)

    • Figure China Prostate Cancer Medicine Price Trend, by Type (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Value, by Application (2017-2028)

    • Table Global Prostate Cancer Medicine Sales Value Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Medicine Sales Value Share, by Application (2017-2028)

    • Table China Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table China Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Table China Prostate Cancer Medicine Sales Value, by Application (2017-2028)

    • Table China Prostate Cancer Medicine Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prostate Cancer Medicine Production, Import, Consumption and Export (2017-2022)

    • Table North America Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table North America Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure North America Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table North America Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table North America Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure North America Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure United States Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Table Europe Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table Europe Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table Europe Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table Europe Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Table APAC Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table APAC Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table APAC Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table APAC Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Medicine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Medicine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Medicine Sales Value and Growth Rate (2017-2028)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Active Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Active Biotech Product Profiles, Application and Specification

    • Table Active Biotech Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc Product Profiles, Application and Specification

    • Table Astellas Pharma Inc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Holding AG Product Profiles, Application and Specification

    • Table Roche Holding AG Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceuticals Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceuticals Industries Ltd Product Profiles, Application and Specification

    • Table Teva Pharmaceuticals Industries Ltd Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol Myers-Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol Myers-Squibb Product Profiles, Application and Specification

    • Table Bristol Myers-Squibb Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca plc Product Profiles, Application and Specification

    • Table AstraZeneca plc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Prostate Cancer Medicine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US